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Abstract 
Objective 
This work aims to validate and increase understanding of the Global Activity Limitation Index (GALI), 
an activity limitation measure from which the new structural indicator Healthy Life Years (HLY) is 
generated. 
 
Study design and setting 
Data from the Survey of Health and Retirement in Europe (SHARE), covering 11 European countries 
and 27 340 individuals of over 50 years of age, was used to investigate how the GALI was associated 
with other existing measures of function and disability, and whether the GALI was consistent or 
reflected different levels of health in different countries.  
 
Results 
The GALI was significantly associated with the two subjective measures of activities of daily living 
score and instrumental activities of daily living score, and the two objective measures of maximum grip 
strength and walking speed (p<0.001 in all cases). The GALI did not differ significantly between 
countries in terms of how it reflected three of the health measures, with the exception being 
instrumental activities in daily living (IADL).  
 
Conclusions 
The GALI appears to satisfactorily reflect levels of function and disability as assessed by longer-
standing objective and subjective measures, both across Europe and in a similar way between countries.  
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Introduction 
Health expectancies, combining information on mortality and morbidity, have become essential 
indicators of the health of our ageing populations, where the quality of remaining life is seen as at least 
as important as the quantity. Europe is no exception and indeed has now introduced a disability-free 
life expectancy, called the Healthy Life Year (HLY) as the first European structural indicator on 
health.(1) These indicators are to be monitored annually by the Spring Council meeting (European 
Commission 2003 and 2004).  
 
A major purpose of monitoring health expectancies is to determine whether the year on year increases 
in life expectancy, still evident in the majority of countries, are accompanied by decreases in unhealthy 
life years (known as the compression of morbidity hypothesis) (2-5), or by increases in unhealthy life 
years (expansion of morbidity).(2, 4-6) Despite the commonly held view that the endpoint of the 
epidemiological transition is the compression of morbidity, Robine & Michel(5) have suggested that 
further life expectancy increases and the emergence of greater numbers of the oldest old might result in 
further expansion of disability. Analysing three chronological series, they have demonstrated that the 
proportion of years lived in good health have decreased in Australia, remained constant in Great Britain 
and increased in Austria and that this was related to the initial level of life expectancy. They suggest 
that expansion of disability goes with the highest life expectancy and compression with the lowest.(5)  
 
Although health expectancies are available for over 50 countries worldwide, including many European 
countries, Robine and Michel’s hypothesis is difficult to confirm because differences in the underlying 
health measure and in the methods of calculation hamper harmonization. To date cross-national 
comparisons of health expectancies across Europe have been few and have relied on post rather than 
pre collection harmonisation. The Cross National Determinants of Quality of Life and Health Services 
for the Elderly project (CLESA) is the first attempt to make a cross-national comparison of disability-
free life expectancy (DFLE) using data from five European countries (Finland, Italy, The Netherlands, 
Spain and Sweden) and Israel.(7) Even when longitudinal analysis was possible CLESA has major 
disadvantages since the activities of daily living (ADL) measures were collected in different periods 
from 1987 to 1993 (baseline) and from 1990 to 2000 (follow-up), with various response categories, and 
with data being harmonised post-collection.(8) Although Italy showed the lowest total life expectancy 
without disability among both men (72%) and women (61%) and Sweden the highest (89% among men 
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and 71% among women), it is difficult to determine whether or not these differences in DFLE are real. 
A few countries (France, UK, Belgium, Ireland, Netherlands, United States, Switzerland and Australia) 
have attempted to estimate Dementia Free Life Expectancy but again cross-national comparisons are 
difficult due to differing diagnostic instruments, a lack of harmonisation of case-definitions and, in 
some countries, omission of those in institutions.(9, 10) 
 
According to the recent RAND Europe report, HLY will be distinguished from other indicators of 
health expectancy by harmonisation at the point of collection which allows comparability across 
countries.(11) HLY is based on a Global Activity Limitation question (GALI) from the Statistics on 
Income and Living Conditions (SILC) survey. The GALI, which has been designed particularly for 
health expectancy comparisons across Europe(12, 13), has only been validated to date against other 
measures of health and function in one country, Belgium.(12, 14) Other than the GALI, there are only a 
very limited number of questions on health and functioning in the SILC, which restricts further 
validation of the GALI in other languages and cultures. However the GALI was included in the Survey 
of Health and Retirement in Europe (SHARE) alongside a wide range of other disability measures. 
SHARE was based on the US Health and Retirement Survey (HRS) and was conducted in 2004 on 
individuals aged 50 years and over in 11 European countries: Germany, Austria, Belgium, Denmark, 
Spain, France, Greece, Italy, Netherlands, Sweden and Switzerland.  
 
As the GALI will be used to monitor levels of health within and between countries through the HLY 
indicator, it is important to understand what the GALI is actually measuring and to check its 
robustness. Using data from SHARE this paper aims to validate the GALI for the first time in multiple 
European countries and to investigate whether the GALI reflects similar levels of disability and 
functioning in different countries.  
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Methods 
The sample size for SHARE ranged from 947 (Switzerland) to 3671 (Belgium) persons per 
participating country (table 1), representing the non-institutionalized population aged 50 and older.(15) 
The SHARE main questionnaire consists of 20 modules (supplemented by a self-completion 
questionnaire). The GALI is self-reported whereby an individual is asked “For the past six months at 
least, to what extent have you been limited because of a health problem in activities people usually 
do?” There are three possible responses: not limited, moderately limited or severely limited. Due to the 
low numbers reporting themselves as severely limited in the SHARE study, the severely and 
moderately limited individuals were merged into one category classed (limited), as is also done when 
calculating the HLY indicator.(1) To investigate the validity of the GALI we compared it to a number 
of other common measures of function and disability which were simultaneously collected, including 
maximum grip strength, walking speed (only measured in those aged over 75 years and those under 75 
years with self-reported walking limitation), an activities of daily living score (ADL) and an 
instrumental activities of daily living score (IADL). Further details of these measures are given in 
Appendix 1. Both ADLs and IADLs were self-reported, and therefore essentially subjective, whereas 
both maximum grip strength and walking speed can be considered objective measure, being measured 
using consistent techniques across countries. Further details of the SHARE data and methodology can 
be found in previous publications.(16) 
 
Statistical methods 
To assess the relationship between the GALI and the other functioning and disability measures, logistic 
regression models were fitted, adjusting for age, gender and the clustering effect of country. The 
probability of being classed as limited or not limited for the GALI for each value or category of the 
measure of function or disability of interest could then be estimated from the logistic regression 
models, and the relationships assessed. Additional models were also fitted to assess if the relationship 
between the GALI and other measures differed by country. This was done by firstly fitting logistic 
regression models for each country individually, to estimate the odds of being limited or not limited by 
different measures, adjusted for age. For this analysis the continuous measures were dichotomised, 
using cut-offs provided by SHARE. These were, for walking speed <=0.4 metres/second versus >0.4 
metres/second and for both ADLs and IADLs a score of one or more versus none. For maximum grip 
strength a binary version of the variable was not included in the SHARE dataset, therefore the variable 
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was dichotomised using gender-specific tertiles across all countries, with the lower third (poor grip 
strength) forming one category, compared to all others. The odds ratios from the logistic regression 
models were then compared by assessing heterogeneity between countries by fitting random effects 
meta-analysis models for each health measure of interest.  
 
 
Results 
The characteristics of the SHARE study sample are described by country in Table 1. The country 
cohorts were fairly similar in terms of age and gender composition, with a mean age of between 63.9 
years (Netherlands) to 66.9 years (Spain), and percentage of males varying from 42.1% (Spain) to 
47.4% (Sweden).  The percentage describing themselves as limited varied considerably by country and 
was highest in Germany (49.5%) and lowest in Greece (30.4%). Other measures of disability and 
functioning, both objective and subjective, also showed variations across Europe. The percentages who 
reported difficulty with at least one ADL or one IADL were lowest in Switzerland (6.8% and 8.5% 
respectively) and highest in Spain (14.1% and 25.4%). 
 
(Table 1 here) 
 
We first explored whether the GALI reflected disability and function on other measures overall using 
logistic regression models and these results are reported in Figure 1 and Table 2. In all cases the GALI 
significantly reflected poorer function as assessed by the other measures (p<0.001 in all cases). For 
example Figure 1 shows that as maximum grip strength increased, the probability of reporting 
limitation with the GALI decreased, and as the number of ADL and IADL restrictions increased so did 
the probability of being limited. On the other hand the probability of reporting no limitation with the 
GALI if limited on the other measures was non-zero, though small and a minimum with the most 
severe measure (ADL). The SHARE study did however appear to provide strong evidence that overall 
the GALI effectively captured limitation as measured by other subjective and objective disability and 
functioning items. 
 
(Figure 1 and Table 2 here) 
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Next we undertook analyses to determine if the GALI measured the same level of functioning and 
disability across countries, that is, were the individuals identified as limited in one country similar to 
those identified in another. For each country the limited group had poorer function however this 
measured, as can be seen in Table 3, where crude unadjusted values are reported for each GALI 
classification. However the prevalence of each of the other disability and function measures between 
the groups who were limited and not limited by the GALI appeared to vary by country, indicating that 
the GALI could be identifying different groups of individuals in different countries. This was further 
investigated by fitting logistic regression models for each country to obtain an odds ratio of being 
limited dependent on different function and disability measures, and then investigating the odds ratios 
for heterogeneity across countries. Figure 2 shows that there was no significant country variation in the 
odds of being limited dependent on each measure: ADL (p=0.106), maximum grip strength (p=0.077) 
and walking speed (p= 0.524). There was however significant heterogeneity for IADL score (p<0.001). 
From Figure 2(b) it can be seen that the odds ratios of being assessed as limited by the GALI if an 
individual had difficulties with one or more IADLs compared to none, varied from an odds ratio of3.85 
(95% CI: 2.94, 4.76) for Greece to 9.42 (95% CI: 6.66, 12.18) for Sweden. Therefore although all 
countries showed increased odds of being limited if an individual had difficulty with at least one IADL, 
the relationship was more pronounced in some countries compared to others. In general from Figure 2, 
it can be seen that within each country there was mostly a significant association between the GALI 
score and other measures and furthermore this was always in the direction that would be expected, i.e. 
individuals with poorer functioning and disability measures were more likely to be classed as limited 
by the GALI. 
 
(Table 3 and Figure 2 here) 
 
In terms of gender and age comparisons for those with missing compared to recorded data, the only 
significant difference was for grip strength where participants with missing data were on average older 
(missing grip strength: mean age=70.1 years; recorded grip strength mean age = 64.6 years; p<0.0001). 
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Discussion 
The Global Activity Limitation Index (GALI) is a new single item disability measure developed to 
allow consistent monitoring of the health of the European population.(1) The GALI and two other 
single item questionnaires on self-rated health and chronic morbidity form the Minimum European 
Health Module, which is included in the European Union Statistics of Income and Living Conditions 
Survey (EU-SILC), now running in all 27 countries in the European Union. The importance of the 
GALI makes it imperative that its properties are fully evaluated and understood. To date the GALI has 
only undergone validation in one European country.(12, 14) In contrast the analysis presented here is 
based on a large data set of over 27,000 individuals from 11 European countries, and is therefore the 
first cross-national validation of the GALI. As in the single country validation, we found that generally 
the GALI appeared to be a good indicator of poor function and disability, as reflected by other 
subjective and objective measures.  
 
Previous cross-European studies such as the European Community Household Panel (ECHP) included 
a similar question to the GALI from which disability-free life expectancy has been calculated.(17, 18)  
However countries individually translated the question and response categories into their own language 
and no checks were made on whether there were any cultural issues that were likely to impair 
understanding or reporting. The GALI, on the other hand, was developed in a bottom-up approach, 
systematically reviewing all global disability questions and then forming the English version with a 
clear definition of the concepts that the item was measuring.(13) This enabled translation guidelines to 
be developed so that the item could be translated to the underlying concept, thereby ensuring a higher 
degree of harmonisation and a reduction in the possible cultural differences that might occur.   
 
Although attempts have been made to reduce differences in the cultural understanding and reporting of 
the GALI, it remains a self-reported measure of disability and it is still possible that the cross-national 
variation in the GALI may be due to some cultures being more or less reticent about reporting the 
severity of their problems. This is particularly acute when response categories are ordinal such as 
‘none, mild, moderate, severe, extreme’ or in the case of self-rated health ‘excellent, very good, good, 
bad and very bad.’ Older people especially may rate their difficulties as less severe than younger 
people because they subconsciously compare themselves with others of the same age. One strategy for 
overcoming this is the use of anchoring vignettes (19) which are a set of hypothetical individuals with 
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health problems rated by each respondent on the same scale as the original health question, allowing 
the researcher to recalibrate the original response. Although the GALI responses are ordered 
categorical ‘not limited, limited but not severely, severely limited’ HLY are defined as no limitation 
which would appear to be less prone to interpretation than the 3-point Likert items. Despite this there 
were a few individuals who were restricted in the other disability and function measures (according to 
the cutpoints we used) who reported no limitation in the GALI and this requires further research.   
 
A strength of our study is the large number of countries covered in the SHARE survey, the wide range 
of measures of functioning and disability including objective measurements and the data quality in 
terms of completeness. Out of 27,340 individuals in the SHARE data set who were over 50 years of 
age, 27178 (99%) were analysed for ADL and IADL, 25080 (92%) for maximum grip strength, and 
27,170 (99%) had data available for the GALI, though only 2525 (49% of those over 75 years of age) 
had walking speed recorded. Those missing on grip strength were significantly older than those with 
recorded data but the level of missing data for this variable was low overall (8%).  
 
Measures of disability were introduced into Health Interview Surveys as self-rated health was felt to be 
too subjective (despite it correlating well with mortality and health service use (20)) and reported 
morbidity is sensitive to change over time, level of education, and medical advances. Disability was 
thought to be more objective, easier to identify by individuals, easier to report (though still subjective 
as self-reported) and important in determining need not only for health services but also for long-term 
care.(21) Disability is usually measured through basic personal care Activities of Daily Living (22) 
and/or Instrumental Activities of Daily Living (23) and these often take the form of a minimum of 5 
separate questions although there is a wider range of potential items for any particular survey. A single 
item on disability such as the GALI is particularly useful therefore for inclusion  in non-health surveys 
such as the Labour Force Surveys. We have shown that the GALI satisfactorily reflects poor 
functioning and disability on a range of subjective and objective items and in a similar manner across 
different European countries. The GALI therefore appears to be a useful addition to European surveys 
where time constraints make a longer set of ADLs or IADLs impossible as well as a firm basis for the 
HLY indicator.  
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Figure 2: Comparison of the odds of being limited by the GALI and other measures 
of disability and function, by country 
(p-values reflect a test for heterogeneity between countries) 
 
a) One or more ADLs compared to none 
 
Odds ratio of being limited, one or more ADLs compared to none
1 5 10 15 20 25
 Combined
 Austria
 Spain
 Sweden
 Italy
 Switzerland
 Germany
 Denmark
 Belgium
 Greece
 Netherlands
 France
 
 
b) One or more IADLs compared to none 
Odds ratio of being limited, one or more IADLs compared to none
1 5 10 15
 Combined
 Sweden
 Denmark
 Switzerland
 Austria
 France
 Belgium
 Spain
 Italy
 Netherlands
 Germany
 Greece
 
p=0.106 
 
p<0.001 
 
  
c) Maximum grip strength, lower tertile compared to upper two tertiles 
Odds ratio of being limited, by maximum grip strength
1 2 3 4
 Combined
 Denmark
 Italy
 Belgium
 Spain
 Switzerland
 France
 Netherlands
 Germany
 Sweden
 Austria
 Greece
 
 
d) Walking speed of <=0.4m/sec compared to >0.4m/sec (age 75+ only)   
Odds ratio of being limited, by walking speed
1 5 10 15
 Combined
 Switzerland
 France
 Germany
 Belgium
 Netherlands
 Sweden
 Spain
 Greece
 Denmark
 Austria
 Italy
 
p=0.077 
 
p=0.524 
 
  
Appendix 1: Functioning and disability measures 
Measure SHARE Categories Process 
Global Activity 
Limitation Index 
(GALI) 
For the past six months at 
least, to what extent have 
you been limited because 
of a health problem in 
activities people usually 
do? 
SHARE: 1. Severely 
limited 
2. Limited, but not 
severely 
3. Not limited 
 
 
This variable was 
aggregated resulting in 
two categories: (0) not 
limited & (1) limited.  
 
Activities of 
Daily Living 
(ADL) 
Please tell me if you have 
any difficulty with these 
because of a physical, 
mental, emotional or 
memory problem. 
1. Dressing, 
including putting on 
shoes and socks 
2. Walking across a 
room 
3. Bathing or 
showering 
4. Eating, such as 
cutting up your food 
5. Getting in or out 
of bed 
6. Using the toilet, 
including getting up 
or down 
If they had problems with 
at least one of the 
activities, then they were 
classified as having 
restrictions.  
 
Instrumental 
activities of daily 
living (IADL) 
Please tell me if you have 
any difficulty with these 
because of a physical, 
mental, emotional or 
memory problem. 
7. Using a map to 
get around in a 
strange place 
8. Preparing  a hot 
meal 
9. Shopping for 
groceries 
10. Making 
telephone calls 
11. Taking 
medications 
12. Doing work 
around the house or 
garden 
13. Managing 
money, e.g. paying 
bills & keeping track 
of expenses 
If they had problems with 
at least one of the 
activities, then they were 
classified as having 
restrictions. 
 
 
